REGULATORY INTELLIGENCE·Recall
FDA Class II Recall: Cardinal Health's Tiotropium Bromide Distribution Impacted by CGMP Deviations
Cardinal Health initiated a Class II recall for 5 units of SPIRIVA HANDIHALER (tiotropium bromide) due to CGMP deviations involving temperature excursions. This terminated recall underscores the critical need for robust cold chain management and quality assurance protocols within pharmaceutical distribution networks, directly impacting procurement and regulatory compliance strategies for global chemical and life sciences firms.
90-Day Activity